Literature DB >> 12465720

Gastro-oesophageal reflux in obese subjects: influence of overweight, weight loss and chronic gastric balloon distension.

E M H Mathus-Vliegen1, G N J Tygat.   

Abstract

BACKGROUND: Gastro-oesophageal reflux is an obesity-related health risk assumed to improve after weight loss. Prolonged intragastric balloon distension might oppose this. The purpose of the study was to investigate the prevalence of gastro-oesophageal reflux in untreated obese subjects and to study the consequences of weight loss with or without intragastric balloon treatment.
METHODS: Patients participating in a randomized double-blind, sham-controlled trial received balloon or sham treatment for the first 13 weeks. Thereafter, all subjects received a balloon for the remaining year. Twenty-four-hour pH recordings were made at the start, after 13 weeks of balloon or sham treatment, after 26 and 52 weeks of balloon treatment and 13 weeks after balloon removal.
RESULTS: Group-wise, pH data of 42 untreated patients (BMI 43.4 kg/m2) were highly abnormal. On an individual level, 22 subjects (52%) had some evidence of reflux, 17 patients (40%) showed pathological total reflux times and 8 (19%) had combined total, upright and supine reflux with grade B reflux oesophagitis in only one patient. Albeit poorly, oesophageal acid exposure was related to body weight and visceral fat distribution. A reduction in acid reflux was observed in sham-treated weight-losing subjects, whereas in balloon-treated subjects supine reflux and duration of the longest reflux increased. In the second 13-week period, the initially improved pH values worsened by balloon placement in sham-treated subjects. Values in balloon-balloon-treated subjects stabilized. After 52 weeks, acid reflux levelled off at pretreatment values and further improved after balloon removal. At these times, decreased visceral fat masses correlated significantly with diminished oesophageal exposure to acid.
CONCLUSIONS: Obesity predisposed to gastro-oesophageal reflux. Body weight loss and, strikingly, visceral fat loss resulted in improved reflux parameters. Adverse effects on acid reflux by gastric balloon distension wore off over time.

Entities:  

Mesh:

Year:  2002        PMID: 12465720     DOI: 10.1080/003655202761020498

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  28 in total

1.  Gastrointestinal complications of bariatric Roux-en-Y gastric bypass surgery.

Authors:  Kumaresan Sandrasegaran; Arumugam Rajesh; Chandana Lall; Gerardo A Gomez; John C Lappas; Dean D Maglinte
Journal:  Eur Radiol       Date:  2004-11-10       Impact factor: 5.315

2.  Functional Gastrointestinal Disorders in Obese Patients. The Importance of the Enrollment Source.

Authors:  Michel Bouchoucha; Marinos Fysekidis; Chantal Julia; Gheorghe Airinei; Jean-Marc Catheline; Gérard Reach; Robert Benamouzig
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

Review 3.  Filling the Void: A Review of Intragastric Balloons for Obesity.

Authors:  Patrick Laing; Tuan Pham; Linda Jo Taylor; John Fang
Journal:  Dig Dis Sci       Date:  2017-04-18       Impact factor: 3.199

Review 4.  Operative Treatments for Reflux After Bariatric Surgery: Current and Emerging Management Options.

Authors:  Daniela Treitl; Derek Nieber; Kfir Ben-David
Journal:  J Gastrointest Surg       Date:  2017-01-13       Impact factor: 3.452

5.  24-h pH-metry and multichannel intraluminal impedance monitoring in obese patients with and without gastroesophageal reflux disease symptoms.

Authors:  Giorgio Ricci; Calogero Amella; Edoardo Forti; Angelo Rossi; Gianluca Bersani; Silvia Dari; Veronica Pasini; Antonella Maimone; Vittorio Alvisi
Journal:  Obes Surg       Date:  2011-01       Impact factor: 4.129

6.  Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

Authors:  Shobna J Bhatia; Govind K Makharia; Philip Abraham; Naresh Bhat; Ajay Kumar; D Nageshwar Reddy; Uday C Ghoshal; Vineet Ahuja; G Venkat Rao; Krishnadas Devadas; Amit K Dutta; Abhinav Jain; Saurabh Kedia; Rohit Dama; Rakesh Kalapala; Jose Filipe Alvares; Sunil Dadhich; Vinod Kumar Dixit; Mahesh Kumar Goenka; B D Goswami; Sanjeev K Issar; Venkatakrishnan Leelakrishnan; Mohandas K Mallath; Philip Mathew; Praveen Mathew; Subhashchandra Nandwani; Cannanore Ganesh Pai; Lorance Peter; A V Siva Prasad; Devinder Singh; Jaswinder Singh Sodhi; Randhir Sud; Jayanthi Venkataraman; Vandana Midha; Amol Bapaye; Usha Dutta; Ajay K Jain; Rakesh Kochhar; Amarender S Puri; Shivram Prasad Singh; Lalit Shimpi; Ajit Sood; Rajkumar T Wadhwa
Journal:  Indian J Gastroenterol       Date:  2019-12-05

Review 7.  Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis.

Authors:  Iñaki Imaz; Carmen Martínez-Cervell; Elvira Elena García-Alvarez; Juan Manuel Sendra-Gutiérrez; Jesús González-Enríquez
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

8.  Safety of the Ullorex oral intragastric balloon for the treatment of obesity.

Authors:  Corby K Martin; Drake E Bellanger; Kristina K Rau; Sandra Coulon; Frank L Greenway
Journal:  J Diabetes Sci Technol       Date:  2007-07

Review 9.  Efficacy of First-Time Intragastric Balloon in Weight Loss: a Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Alan A Saber; Saeed Shoar; Mahmoud W Almadani; Natan Zundel; Mohammed J Alkuwari; Moataz M Bashah; Raul J Rosenthal
Journal:  Obes Surg       Date:  2017-02       Impact factor: 4.129

10.  Prevalence of overweightedness in patients with gastro-esophageal reflux.

Authors:  Luca Piretta; Federico Alghisi; Fiorella Anzini; Enrico Corazziari
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.